These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32668704)

  • 1. Inter-Tumor Heterogeneity-Melanomas Respond Differently to GM-CSF-Mediated Activation.
    Moshe A; Izraely S; Sagi-Assif O; Malka S; Ben-Menachem S; Meshel T; Pasmanik-Chor M; Hoon DSB; Witz IP
    Cells; 2020 Jul; 9(7):. PubMed ID: 32668704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo human melanoma cytokine production: inverse correlation of GM-CSF production with tumor depth.
    Hensley C; Spitzler S; McAlpine BE; Lynn M; Ansel JC; Solomon AR; Armstrong CA
    Exp Dermatol; 1998 Dec; 7(6):335-41. PubMed ID: 9858136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanoma.
    Hoeller C; Michielin O; Ascierto PA; Szabo Z; Blank CU
    Cancer Immunol Immunother; 2016 Sep; 65(9):1015-34. PubMed ID: 27372293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma exosome induction of endothelial cell GM-CSF in pre-metastatic lymph nodes may result in different M1 and M2 macrophage mediated angiogenic processes.
    Hood JL
    Med Hypotheses; 2016 Sep; 94():118-22. PubMed ID: 27515216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration.
    Kohn EC; Hollister GH; DiPersio JD; Wahl S; Liotta LA; Schiffmann E
    Int J Cancer; 1993 Apr; 53(6):968-72. PubMed ID: 8473054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM-CSF promotes migration of human monocytes across the blood brain barrier.
    Vogel DY; Kooij G; Heijnen PD; Breur M; Peferoen LA; van der Valk P; de Vries HE; Amor S; Dijkstra CD
    Eur J Immunol; 2015 Jun; 45(6):1808-19. PubMed ID: 25756873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha is necessary for granulocyte-macrophage-colony-stimulating-factor-induced eosinophil transendothelial migration.
    Erger RA; Casale TB
    Int Arch Allergy Immunol; 1998 Jan; 115(1):24-32. PubMed ID: 9430492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of murine melanoma growth by granulocyte-macrophage colony stimulating factor gene transfection is not haplotype specific.
    Botella R; Sarradet MD; Potter LE; Lawley M; Galloway TH; Ansel JC; Armstrong CA
    Melanoma Res; 1998 Jun; 8(3):245-54. PubMed ID: 9664146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma.
    Smith II JW; Kurt RA; Baher AG; Denman S; Justice L; Doran T; Gilbert M; Alvord WG; Urba WJ
    J Immunother; 2003; 26(2):130-8. PubMed ID: 12616104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of granulocyte/macrophage-colony-stimulating factor secretion by human melanoma cells and its effects on human melanoma cell proliferation.
    Schadendorf D; Worm M; Czarnetzki BM
    J Cancer Res Clin Oncol; 1993; 119(8):501-3. PubMed ID: 8509442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor-induced antibody-dependent cellular cytotoxicity in bone marrow macrophages: application in bone marrow transplantation.
    Charak BS; Agah R; Mazumder A
    Blood; 1993 Jun; 81(12):3474-9. PubMed ID: 8507882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
    Slingluff CL; Petroni GR; Yamshchikov GV; Barnd DL; Eastham S; Galavotti H; Patterson JW; Deacon DH; Hibbitts S; Teates D; Neese PY; Grosh WW; Chianese-Bullock KA; Woodson EM; Wiernasz CJ; Merrill P; Gibson J; Ross M; Engelhard VH
    J Clin Oncol; 2003 Nov; 21(21):4016-26. PubMed ID: 14581425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility to generate monocyte-derived dendritic cell from coculture with melanoma tumor cells in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-4.
    Kim YT; Hersh EM; Trevor KT
    Am J Reprod Immunol; 2003 Apr; 49(4):230-8. PubMed ID: 12852497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEL-P, a GM-CSF-producing human melanoma cell line.
    Ciotti P; Imro A; Scudeletti M; Rainero ML; Defferrari R; Ghiorzo P; Indiveri F; Bianchi-Scarrà G
    Melanoma Res; 1996 Jun; 6(3):203-13. PubMed ID: 8819123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
    Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma.
    Domingo-Musibay E; Heun JM; Nevala WK; Callstrom M; Atwell T; Galanis E; Erickson LA; Markovic SN
    Oncologist; 2017 Sep; 22(9):1026-e93. PubMed ID: 28679643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.
    Fukuda M; Horibe K; Furukawa K
    Int J Mol Med; 1998 Oct; 2(4):471-5. PubMed ID: 9857237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-3 and granulocyte-macrophage colony-stimulating factor inhibits tumor necrosis factor (TNF)-alpha-induced osteoclast differentiation by down-regulation of expression of TNF receptors 1 and 2.
    Yogesha SD; Khapli SM; Wani MR
    J Biol Chem; 2005 Mar; 280(12):11759-69. PubMed ID: 15653694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells.
    Armstrong CA; Botella R; Galloway TH; Murray N; Kramp JM; Song IS; Ansel JC
    Cancer Res; 1996 May; 56(9):2191-8. PubMed ID: 8616871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
    Shi FS; Weber S; Gan J; Rakhmilevich AL; Mahvi DM
    Cancer Gene Ther; 1999; 6(1):81-8. PubMed ID: 10078967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.